Is it required to routinely check fibrinogen level in patients with rheumatic diseases on tocilizumab? Case-based review
Sign Up to like & getrecommendations! Published in 2019 at "Rheumatology International"
DOI: 10.1007/s00296-019-04268-x
Abstract: Tocilizumab (TCZ) may rarely cause hematological side effects including neutropenia and thrombocytopenia. TCZ is essentially expected to lower the fibrinogen levels to stay within the normal range, but TCZ-induced hypofibrinogenemia has been rarely reported in… read more here.
Keywords: fibrinogen; tcz; routinely check; review ... See more keywords